Top Markets
#1 Islamic Coin Islamic Coin +152.24%
#2 Bitway Bitway +39.12%
#3 Wrapped STX (Velar) Wrapped STX (Velar) +37.70%
#4 aelf aelf +32.50%
#5 Starpower Starpower +24.83%
#6 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +24.32%
#7 Pons Pons +22.88%
#8 Decred Decred +14.71%
#9 DAPPOS DAPPOS +11.21%
#10 Talus Network Talus Network +10.95%
Coin of the day
Islamic Coin Islamic Coin
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
AIkido Pharma Inc. AIkido Pharma Inc.

AIkido Pharma Inc.

AIKI
Classifica tra le azioni #30001
AIkido Pharma Inc., established in 1967 and headquartered in New York, New... AIkido Pharma Inc., established in 1967 and headquartered in New York, New York, is a biotechnology company primarily engaged in pioneering small-molecule anti-cancer treatments. The firm, which operated as Spherix Incorporated until its rebranding in March 2021, possesses a robust therapeutic pipeline addressing various malignancies, including prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. Key drug candidates in its development portfolio include DHA-dFdC, targeting pancreatic cancer, and KPC34, a small molecule designed for the treatment of both AML and acute lymphoblastic leukemia. Furthermore, AIkido Pharma Inc. is advancing an antiviral platform engineered to hinder the proliferation of numerous viruses, such as the influenza virus, Ebolavirus, Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2. The company holds strategic license agreements with several academic and research institutions, including the University of Texas, University of Maryland Baltimore, Silo Pharma Inc., and Wake Forest University Health Sciences.
Prezzo delle azioni
$3.56
Ultima sincronizzazione: 2022-12-21
Capitalizzazione di mercato
$18.70M
Variazione (1 giorno)
0.28%
Variazione (1 anno)
0.00%
Paese
US
Scambia AIkido Pharma Inc. (AIKI)

Categoria

Healthcare
Utile per AIkido Pharma Inc. (AIKI)
Utile nel 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di AIkido Pharma Inc., gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, uguale a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Storico degli utili di AIkido Pharma Inc. dal 2026 al 2026
Utile alla fine di ogni anno
Anno Utile Cambia
Non abbastanza dati per le date fornite.
Utile per aziende simili o concorrenti
Azienda Utile Differenza negli utili Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR